Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Yues International Holdings Group Limited ( (HK:1529) ).
Yues International Holdings Group Limited has announced the acquisition of Bozhou Lelaohao Medical Co., Ltd., a company engaged in the wholesale and distribution of pharmaceutical products. This acquisition aligns with Yues International’s strategic objectives to enhance its logistics capabilities in the Chinese medicine sector and expand its supply chain services. The company plans to integrate digital technologies and AI to improve operational efficiency and explore further opportunities along the industry chain, while also addressing potential risks in compliance, supply chain management, and quality control to enhance market competitiveness.
More about Yues International Holdings Group Limited
Yues International Holdings Group Limited operates in the pharmaceutical industry, focusing on the wholesale and distribution of pharmaceutical products, medical devices, and protective medical supplies. The company is strategically positioned in the traditional Chinese medicine sector, aiming to connect manufacturing with retail pharmacies and hospitals.
Average Trading Volume: 918,982
Technical Sentiment Signal: Sell
Current Market Cap: HK$226.8M
For detailed information about 1529 stock, go to TipRanks’ Stock Analysis page.